About Janet

Janet has more than 20 years expertise in market access, specialty pharmacy, brand management, strategy, and communications, with a focus in specialty and biologics, particularly oncology. As Director, Strategic Solutions at Magellan Rx/ICORE Healthcare, she drove access and reimbursement strategies, payer value messaging, and actionable strategies for oral oncolytics and medical benefit products including cross-benefit initiatives. Previous roles working with the teams at onPoint Oncology and DK Pierce & Associates informed commercial payer, employer, and public payer access and reimbursement initiatives.

Janet joined Hobart Group Holdings, a Precision Medicine Group predecessor company, in 2013. Currently at PRECISIONvalue, she brings strategic vision and voice of the customer expertise to client market access strategy and tactical plan execution. Her understanding of oncology runs deep; from the dynamic policy environment including CMS initiatives like the OCM/OCF, to first-in-class therapeutic options and companion diagnostics, LOE strategies, and the evolving influencers on the practice of oncology in both the community and academic settings, including clinical pathways developers. She has launched market-making drugs and biologics and supported favorable coverage determinations by public and private payers.

EDUCATION:
BA, cum laude,Temple University
MS, Drexel University
adjunct graduate faculty member, Webster University

MEMBERSHIPS:
Academy of Managed Care Pharmacy (AMCP)